<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Aledade — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
<header class="site-header"><h1>Prospect Detail</h1></header>
<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>47. Aledade</h1>
    <p class="meta">Primary Care ACO Network</p>
  </div>
  <div class="section"><h3>1. Startup Name</h3><p><strong>Aledade</strong></p></div>
  <div class="section"><h3>2. Founder Contact</h3><p><strong>Farzad Mostashari, MD MPH</strong> — Co-Founder & CEO</p><p>Harvard T.H. Chan School of Public Health MPH</p><p>Former National Coordinator for Health IT under Obama administration</p></div>
  <div class="section"><h3>3. Product Overview</h3><p>Aledade is the nation's largest network of independent primary care practices organized into accountable care organizations (ACOs). The company helps practices succeed in value-based care, saving Medicare over $1 billion in 2024 while improving quality for 1M+ patients.</p></div>
  <div class="section"><h3>4. Funding Stage</h3><p><strong>Late Stage / Unicorn</strong> — Raised $500M+ from ICONIQ, Venrock, GV, and others. Valued at $3.1B+.</p></div>
  <div class="section"><h3>5. How I Found the Company</h3><p>Discovered as a prominent Harvard Chan School alumni success story in value-based care transformation.</p></div>
  <div class="strengths-weaknesses">
    <div class="section"><h3>Strengths</h3><ul><li><strong>Massive scale and impact:</strong> $1B+ Medicare savings demonstrates clear value creation.</li><li><strong>Policy expertise:</strong> Founder's government experience provides unique regulatory insight.</li></ul></div>
    <div class="section"><h3>Weaknesses</h3><ul><li><strong>Late-stage valuation:</strong> $3B+ valuation limits upside for new investors.</li><li><strong>Medicare policy dependence:</strong> Changes in CMS ACO rules could impact business model.</li></ul></div>
  </div>
  <div class="section"><h3>7. Five Questions for the Team</h3><ol class="questions-list"><li>What is your current practice count and patient lives under management?</li><li>How do you maintain quality while scaling so rapidly?</li><li>What is your expansion strategy for Medicare Advantage and commercial ACOs?</li><li>How do you compete with other enablement companies like Pearl Health?</li><li>What are your IPO plans or timeline considerations?</li></ol></div>
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>
</body>
</html>
